Following EQT's acquisition in 2020, Recover has invested in its digital capabilities while divesting non-core business units to sharpen focus on water, fire and other core property remediation services

STOCKHOLM, June 24, 2025 /PRNewswire/ -- Recover, a leading Scandinavian property remediation specialist, today announced a change of ownership from EQT VIII ("EQT") and minority investors to industrial investment company Pangea AS.

Recover, which employs approximately 1,730 people across the Nordics, plays a critical role in providing essential restoration services following water, fire, and environmental damage. EQT acquired the Company in early 2020 and despite the challenges presented by the COVID-19 pandemic, Recover has undergone a significant transformation. The Company has been future-proofed through strategic investments in digitization, including a new ERP and FSM system, and has sharpened its focus by divesting non-core business units.

Enity Holding AB (publ), the largest specialist mortgage provider in Sweden, Norway, and Finland, began trading on Nasdaq Stockholm on 13 June 2025. The offering, which was priced at SEK 57 per share, was oversubscribed more than ten times. The share price closed today, on 17 June 2025, at SEK 71.88 per share, implying a market capitalization of SEK 3.6 billion. As part of the offering, the main shareholder (indirectly controlled by EQT (as defined below)) sold shares totaling approximately SEK 1.7 billion (assuming full exercise of the over-allotment option). This will result in aggregate gross proceeds of c. SEK 1.2 billion to EQT (assuming full exercise of the over-allotment option).

THIS IS INFORMATION THAT EQT AB (PUBL) IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SUBMITTED FOR PUBLICATION, THROUGH THE AGENCY OF THE CONTACT PERSON SET OUT BELOW AT 15:00 CEST ON 15 JUNE 2025.

STOCKHOLM, June 15, 2025 /PRNewswire/ -- EQT has today set the target size for EQT XI (or the "Fund") at EUR 23 billion. The actual fund size is dependent on the outcome of the fundraising process and may be higher or lower than the target size; the hard cap of the fund will be set at a later date. EQT XI's investment strategy is expected to be materially in line with the predecessor fund, EQT X.

THIS IS INFORMATION THAT EQT AB (PUBL) IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SUBMITTED FOR PUBLICATION, THROUGH THE AGENCY OF THE CONTACT PERSON SET OUT BELOW AT 15:00 CEST ON 15 JUNE 2025.

STOCKHOLM, June 15, 2025 /PRNewswire/ -- EQT has today set the target size for EQT XI (or the "Fund") at EUR 23 billion. The actual fund size is dependent on the outcome of the fundraising process and may be higher or lower than the target size; the hard cap of the fund will be set at a later date. EQT XI's investment strategy is expected to be materially in line with the predecessor fund, EQT X.

THIS IS INFORMATION THAT EQT AB (PUBL) IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SUBMITTED FOR PUBLICATION, THROUGH THE AGENCY OF THE CONTACT PERSON SET OUT BELOW AT 15:00 CEST ON 15 JUNE 2025.

STOCKHOLM, June 15, 2025 /PRNewswire/ -- EQT has today set the target size for EQT XI (or the "Fund") at EUR 23 billion. The actual fund size is dependent on the outcome of the fundraising process and may be higher or lower than the target size; the hard cap of the fund will be set at a later date. EQT XI's investment strategy is expected to be materially in line with the predecessor fund, EQT X.

Financing was co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investorsProceeds will support the Phase 1/2 clinical development of lead program SB-007 in Stargardt disease, a genetic eye disorder that causes progressive vision loss and blindnessFunding will also advance a broader pipeline of genetic medicines targeting indications in ophthalmology, neurology, and other therapeutic areas

STOCKHOLM, June 11, 2025 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in SpliceBio. The Spanish biotech company is developing novel therapies for genetic diseases – including ophthalmology, neurology, and other therapeutic areas – by leveraging an innovative intein platform. The platform allows large genes to be split into smaller pieces, delivered separately, and then reassembled to create full-length proteins needed to treat diseases.

Series A Funding will be used to advance Mosanna's nasal spray therapy through Phase 2 Clinical TrialsBiotech veteran David Weber has been appointed CEO to lead the company through clinical developmentObstructive sleep apnea (OSA) affects nearly 1 billion people globally, with the majority undiagnosed and underserved with current treatment options

STOCKHOLM, June 9, 2025 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Mosanna Therapeutics ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland, is developing an easy-to-use nighttime nasal spray to treat obstructive sleep apnea (OSA) that aims to restore the body's natural airway control. The financing was led by EQT Life Sciences and Pivotal bioVenture Partners, along with Forbion, Broadview Ventures and Norwest as co-lead investors. Returning investors included founding investor Forty51 Ventures as well as Supermoon Capital and High-Tech Gründerfonds (HTGF).

The sale resulted in aggregate gross proceeds of c. CHF 1.86 billion, of which EQT received c. CHF 494 million

STOCKHOLM, June 3, 2025 /PRNewswire/ -- Further to previous announcements, an affiliate of the funds known as EQT VIII ("EQT") is pleased to announce the completion of the placement of 19,031,811 shares in Galderma Group AG (SIX: GALD) (the "Company") (the "Shares") for aggregate gross proceeds of c. CHF 1.86 billion via an accelerated bookbuilding process (the "Placement"). 

As part of the Placement, EQT received gross proceeds of c. CHF 494 million. The Placement was completed on 2 June 2025. Goldman Sachs, Jefferies, Morgan Stanley, RBC and UBS acted as joint global coordinators and joint bookrunners for the Placement.

The sale resulted in aggregate gross proceeds of c. CHF 1.86 billion, of which EQT received c. CHF 494 million

STOCKHOLM, June 3, 2025 /PRNewswire/ -- Further to previous announcements, an affiliate of the funds known as EQT VIII ("EQT") is pleased to announce the completion of the placement of 19,031,811 shares in Galderma Group AG (SIX: GALD) (the "Company") (the "Shares") for aggregate gross proceeds of c. CHF 1.86 billion via an accelerated bookbuilding process (the "Placement"). 

As part of the Placement, EQT received gross proceeds of c. CHF 494 million. The Placement was completed on 2 June 2025. Goldman Sachs, Jefferies, Morgan Stanley, RBC and UBS acted as joint global coordinators and joint bookrunners for the Placement.

Acquisition of five logistics assets totaling approximately 148,000 square metersLet to nine tenants, this highly reversionary portfolio has a weighted average remaining lease term to break of less than two years           With this transaction, EQT Real Estate will meaningfully increase its exposure to the core Southeast and Southwest France logistics markets

STOCKHOLM, June 2, 2025 /PRNewswire/ -- EQT Real Estate is pleased to announce that EQT Exeter Logistics Value Fund IV has acquired a best-in-class logistics portfolio of five warehouses.

Veteran EQT partner James Yu appointed to EQT's Executive Committee as Head of Client Relations and Capital Raising - overseeing EQT's client relations, capital raising and capital markets teams - as part of an introduction of a more agile and simplified operating model.Chief Commercial Officer Suzanne Donohoe, Bahare Haghshenas, Head of Sustainable Transformation, and Ricardo Reyes, Head of Communications & External Affairs, have decided to step off the Executive Committee and will leave EQT.

STOCKHOLM, June 2, 2025 /PRNewswire/ -- EQT has today announced the appointment of James Yu, who joined EQT in 2013 and most recently served as Global Head of EQT Capital Markets, as Head of Client Relations and Capital Raising. The role brings together responsibility for two of EQT's key client facing teams – Client Relations & Capital Raising and Debt & Equity Capital Markets – as part of EQT's drive to constantly refine and strengthen its operating model. 

Cancellation of 6,899,011 ordinary shares held in treasury by EQTThe cancellation was resolved by the Annual Shareholders' Meeting 2025As of 30 May 2025, there are 1,177,185,346 shares outstanding in EQT

STOCKHOLM, May 30, 2025 /PRNewswire/ -- The total number of shares and votes in EQT AB (publ) ("EQT") has decreased by 6,899,011 shares and votes during May 2025 as a result of a cancellation of 6,899,011 ordinary shares held in treasury by EQT. The cancellation was resolved by the Annual Shareholders' Meeting 2025 on 27 May 2025, in line with EQT's intention to off-set over time the dilution impact from shares delivered to participants in EQT's Share and Option Programs.

Acumatica is a leading next-generation cloud ERP and business management software platform for thousands of small to mid-sized customers around the worldUnder EQT's ownership, Acumatica has transformed into a scaled, vertical business management platform, supported by investments in product innovation and ecosystem expansion across new and existing verticalsAcumatica is well-positioned to capitalize on significant future growth opportunities, including accelerated cloud migration from legacy systems, an expanding partner ecosystem, deeper vertical and horizontal functionality, AI enablement and integrated payment functionality

Acumatica is a leading next-generation cloud ERP and business management software platform for thousands of small to mid-sized customers around the worldUnder EQT's ownership, Acumatica has transformed into a scaled, vertical business management platform, supported by investments in product innovation and ecosystem expansion across new and existing verticalsAcumatica is well-positioned to capitalize on significant future growth opportunities, including accelerated cloud migration from legacy systems, an expanding partner ecosystem, deeper vertical and horizontal functionality, AI enablement and integrated payment functionality

STOCKHOLM, May 27, 2025 /PRNewswire/ -- The Board of EQT AB ("EQT") has resolved to repurchase a maximum of 5,535,521 own ordinary shares. Repurchases may be made during the period 18 July – 26 September 2025.

The resolution is made by virtue of the authorization granted by the Annual Shareholders' Meeting held on 27 May 2025 to repurchase own shares.A maximum of 5,535,521 ordinary shares (0.45% of EQT's share capital) are to be repurchased, and the total maximum amount is SEK 2,500,000,000.The repurchase corresponds to approximately SEK 1,528m based on the closing price for EQT's share on Nasdaq Stockholm on 26 May 20251.Repurchases may be made during the period 18 July – 26 September 2025.As previously communicated, EQT expects to execute share buyback programs twice a year to offset - over time - the dilution impact from shares delivered to EQT's employees under its Share and Option incentive programs.

STOCKHOLM, May 27, 2025 /PRNewswire/ -- Today's Annual Shareholders' Meeting (the "Meeting") voted to support all proposals from the Board and the Nomination Committee. The resolutions passed included the following:

approval of the income statements and the balance sheets for EQT AB and the Group, respectively, for the fiscal year 2024;dividend to the shareholders of SEK 4.30 per share to be paid in two installments. At the first installment SEK 2.15 per share is paid with the record date 30 May 2025. At the second installment SEK 2.15 per share is paid with the record date 1 December 2025. The dividend is expected to be distributed through Euroclear on 4 June 2025 and on 4 December 2025, respectively;discharge of liability for the Board members and the CEO for the fiscal year 2024;re-election of Conni Jonsson, Brooks Entwistle, Diony Lebot, Gordon Orr, Marcus Wallenberg, Margo Cook and Richa Goswami as Board members, election of Jacob Wallenberg Jr as new Board member (conditional upon obtaining necessary regulatory approvals) and re-election of Conni Jonsson as Chairperson of the Board;re-election of KPMG AB as auditor;approval of fees to the Board and auditor;approval of the remuneration report presented by the Board;authorization for the Board to resolve upon issuances of new shares, convertible bonds and/or warrants;authorization for the Board to resolve on repurchase and transfer of own shares;reduction of the share capital through cancellation of ordinary shares held in treasury and increase of the share capital through a bonus issue; andamendment of the EQT Share Program and the EQT Option Program.

Seven Seas Water Group delivers water and wastewater solutions through its Water-as-a-Service® model to communities across the U.S., Caribbean and Latin America, addressing vital segments of the water value chain that are central to resilient supply and require significant long-term investmentTransaction underscores EQT's commitment to investing behind essential infrastructure, partnering with established platforms that deliver sustainable, mission-critical services aligned with global needs for resource efficiencyEQT aims to accelerate Seven Seas Water Group's continued growth and support the Company's mission to provide safe, reliable and cost-effective water and wastewater treatment solutions to the people and regions it operates in

Seven Seas Water Group delivers water and wastewater solutions through its Water-as-a-Service® model to communities across the U.S., Caribbean and Latin America, addressing vital segments of the water value chain that are central to resilient supply and require significant long-term investmentTransaction underscores EQT's commitment to investing behind essential infrastructure, partnering with established platforms that deliver sustainable, mission-critical services aligned with global needs for resource efficiencyEQT aims to accelerate Seven Seas Water Group's continued growth and support the Company's mission to provide safe, reliable and cost-effective water and wastewater treatment solutions to the people and regions it operates in

STOCKHOLM, May 22, 2025 /PRNewswire/ -- Today, EQT will host a Capital Markets Event in London. The presentation will be available on the EQT Group website's Shareholder Relations tab at 1:00 pm BST. 

We will explore EQT's thematic investment focus, repeatable value creation toolbox, and governance model through the lens of several of EQT's portfolio companies: IFS, Reworld, Nord Anglia Education, IVC Evidensia, WS Audiology, and Credila Financial Services. In addition, EQT Industrial Advisors Kate Swann, Dorothy Thompson, and Jonas Person will reflect on their roles and the importance of EQT's governance model.

The offering resulted in aggregate gross proceeds of c. USD557.0 million, of which EQT received c. USD239.6 million

NEW YORK, May 20, 2025 /PRNewswire/ -- An affiliate of the fund known as EQT VIII ("EQT") is pleased to announce the completion of an underwritten public offering (the "Offering") of c. 14.4 million shares of common stock of Waystar Holding Corp. (NASDAQ: WAY) (the "Company") ("Shares"), which included the full exercise of the underwriters' option to purchase c. 1.9 million additional shares of common stock, for aggregate gross proceeds of c. USD557.0 million to all the selling stockholders.  As part of the Offering, EQT sold c. 6.2 million Shares (and now holds c. 32.6 million Shares) and received gross proceeds of c. USD239.6 million. The remaining Shares sold in the Offering were sold by other stockholders of the Company. J.P. Morgan, Goldman Sachs & Co. LLC and Barclays acted as joint book-running managers of the Offering, which was completed with respect to the base Shares on May 16, 2025 and with respect to the additional Shares on May 20, 2025, and as representatives of the several underwriters.  The Company did not sell any Shares in the Offering and did not receive any proceeds from the sale of the Shares sold by EQT and the other stockholders.